Burkholderia cenocepacia is highly resistant to antimicrobial peptides and we hypothesized that the conversion of UDP-glucose to UDP-glucuronic acid, a reaction catalysed by the enzyme UDP-glucose dehydrogenase (Ugd) would be important for this resistance. The genome of B. cenocepacia contains three predicted ugd genes: ugdBCAL2946, ugdBCAM0855 and ugdBCAM2034, all of which were individually inactivated. Only inactivation of ugdBCAL2946 resulted in increased sensitivity to polymyxin B and this sensitivity could be overcome when either ugdBCAL2946 or ugdBCAM0855 but not ugdBCAM2034 was expressed from plasmids. The growth of a conditional ugdBCAL2946 mutant, created in the ΔugdBCAM0855 background, was significantly impaired under non-permissive conditions. Growth could be rescued by either ugdBCAL2946 or ugdBCAM0855 expressed in trans, but not by ugdBCAM2034. Biochemical analysis of the purified, recombinant forms of UgdBCAL2946 and UgdBCAM0855 revealed that they are soluble homodimers with similar in vitro Ugd activity and comparable kinetic constants for their substrates UDP-glucose and NAD+. Purified UgdBCAM2034 showed no in vitro Ugd activity. Real-time PCR analysis showed that the expression of ugdBCAL2946 was 5.4- and 135-fold greater than that of ugdBCAM0855 and ugdBCAM2034, respectively. Together, these data indicate that the combined activity of UgdBCAL2946 and UgdBCAM0855 is essential for the survival of B. cenocepacia but only the most highly expressed ugd gene, ugdBCAL2946, is required for polymyxin B resistance.
AaronS. D.,
FerrisW.,
HenryD. A.,
SpeertD. P.,
MacdonaldN. E.2000; Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia . Am J Respir Crit Care Med 161:1206–1212
AubertD. F.,
FlannaganR. S.,
ValvanoM. A.2008; A novel sensor kinase-response regulator hybrid controls biofilm formation and type VI secretion system activity in Burkholderia cenocepacia . Infect Immun 76:1979–1991
BaderM. W.,
SanowarS.,
DaleyM. E.,
SchneiderA. R.,
ChoU.,
XuW.,
KlevitR. E.,
Le MoualH.,
MillerS. I.2005; Recognition of antimicrobial peptides by a bacterial sensor kinase. Cell 122:461–472
BalandreauJ.,
ViallardV.,
CournoyerB.,
CoenyeT.,
LaevensS.,
VandammeP.2001; Burkholderia cepacia genomovar III is a common plant-associated bacterium. Appl Environ Microbiol 67:982–985
BreazealeS. D.,
RibeiroA. A.,
RaetzC. R.2002; Oxidative decarboxylation of UDP-glucuronic acid in extracts of polymyxin-resistant Escherichia coli . Origin of lipid A species modified with 4-amino-4-deoxy-l-arabinose. J Biol Chem 277:2886–2896
CampbellR. E.,
MosimannS. C.,
van De RijnI.,
TannerM. E.,
StrynadkaN. C.2000; The first structure of UDP-glucose dehydrogenase reveals the catalytic residues necessary for the two-fold oxidation. Biochemistry 39:7012–7023
De LeonG. P.,
EloweN. H.,
KotevaK. P.,
ValvanoM. A.,
WrightG. D.2006; An in vitro screen of bacterial lipopolysaccharide biosynthetic enzymes identifies an inhibitor of ADP-heptose biosynthesis. Chem Biol 13:437–441
FigurskiD. H.,
HelinskiD. R.1979; Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans . Proc Natl Acad Sci U S A 76:1648–1652
FlannaganR. S.,
AubertD.,
KooiC.,
SokolP. A.,
ValvanoM. A.2007; Burkholderia cenocepacia requires a periplasmic HtrA protease for growth under thermal and osmotic stress and for survival in vivo. Infect Immun 75:1679–1689
FlannaganR. S.,
LinnT.,
ValvanoM. A.2008; A system for the construction of targeted unmarked gene deletions in the genus Burkholderia . Environ Microbiol 10:1652–1660
GoldR.,
JinE.,
LevisonH.,
IslesA.,
FlemingP. C.1983; Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia . J Antimicrob Chemother 12:Suppl A331–336
HelanderI. M.,
KilpelainenI.,
VaaraM.1994; Increased substitution of phosphate groups in lipopolysaccharides and lipid A of the polymyxin-resistant pmrA mutants of Salmonella typhimurium : a 31P-NMR study. Mol Microbiol 11:481–487
HoldenM. T.,
Seth-SmithH. M.,
CrossmanL. C.,
SebaihiaM.,
BentleyS. D.,
Cerdeño-TárragaA. M.,
ThomsonN. R.,
BasonN.,
QuailM. A.other authors2009; The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients. J Bacteriol 191:261–277
Iwanicka-NowickaR.,
ZielakA.,
CookA. M.,
ThomasM. S.,
HryniewiczM. M.2007; Regulation of sulfur assimilation pathways in Burkholderia cenocepacia : identification of transcription factors CysB and SsuR and their role in control of target genes. J Bacteriol 189:1675–1688
KoxL. F.,
WöstenM. M.,
GroismanE. A.2000; A small protein that mediates the activation of a two-component system by another two-component system. EMBO J 19:1861–1872
LoutetS. A.,
FlannaganR. S.,
KooiC.,
SokolP. A.,
ValvanoM. A.2006; A complete lipopolysaccharide inner core oligosaccharide is required for resistance of Burkholderia cenocepacia to antimicrobial peptides and bacterial survival in vivo. J Bacteriol 188:2073–2080
MahenthiralingamE.,
CoenyeT.,
ChungJ. W.,
SpeertD. P.,
GovanJ. R.,
TaylorP.,
VandammeP.2000; Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex. J Clin Microbiol 38:910–913
McPheeJ. B.,
BainsM.,
WinsorG.,
LewenzaS.,
KwasnickaA.,
BrazasM. D.,
BrinkmanF. S. L.,
HancockR. E. W.2006; Contribution of the PhoP-PhoQ and PmrA-PmrB two-component regulatory systems to Mg2+-induced gene regulation in Pseudomonas aeruginosa . J Bacteriol 188:3995–4006
MillerV. L.,
MekalanosJ. J.1988; A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR . J Bacteriol 170:2575–2583
MoreiraL. M.,
VideiraP. A.,
SousaS. A.,
LeitãoJ. H.,
CunhaM. V.,
Sá-CorreiaI.2003; Identification and physical organization of the gene cluster involved in the biosynthesis of Burkholderia cepacia complex exopolysaccharide. Biochem Biophys Res Commun 312:323–333
NummilaK.,
KilpelainenI.,
ZähringerU.,
VaaraM.,
HelanderI. M.1995; Lipopolysaccharides of polymyxin B-resistant mutants of Escherichia coli are extensively substituted by 2-aminoethyl pyrophosphate and contain aminoarabinose in lipid A. Mol Microbiol 16:271–278
OrtegaX. P.,
CardonaS. T.,
BrownA. R.,
LoutetS. A.,
FlannaganR. S.,
CampopianoD. J.,
GovanJ. R.,
ValvanoM. A.2007; A putative gene cluster for aminoarabinose biosynthesis is essential for Burkholderia cenocepacia viability. J Bacteriol 189:3639–3644
SilipoA.,
MolinaroA.,
CescuttiP.,
BediniE.,
RizzoR.,
ParrilliM.,
LanzettaR.2005; Complete structural characterization of the lipid A fraction of a clinical strain of B. cepacia genomovar I lipopolysaccharide. Glycobiology 15:561–570
VaaraM.,
VaaraT.,
JensenM.,
HelanderI.,
NurminenM.,
RietschelE. T.,
MäkeläP. H.1981; Characterization of the lipopolysaccharide from the polymyxin-resistant pmrA mutants of Salmonella typhimurium . FEBS Lett 129:145–149
WöstenM. M. S. M.,
KoxL. F. F.,
ChamnongpolS.,
SonciniF. C.,
GroismanE. A.2000; A signal transduction system that responds to extracellular iron. Cell 103:113–125
ZhangL.,
ParenteJ.,
HarrisS. M.,
WoodsD. E.,
HancockR. E.,
FallaT. J.2005; Antimicrobial peptide therapeutics for cystic fibrosis. Antimicrob Agents Chemother 49:2921–2927